Clinical Trial Update: Study of SUPLEXA in Patients With Metastatic Solid Tumours and Haematologic Malignancies [Phase 1]

View source ↗

Summary

Phase 1 study of SUPLEXA in patients with metastatic solid tumors and hematologic malignancies has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies
• Solid Tumors

Drugs mentioned

• SUPLEXA

Snippet

Sponsor: Alloplex Biotherapeutics Inc | Conditions: Oncology | Phase 1 | Status: COMPLETED | Results posted: 2025-09-18